Market research
AMPE Ampio Pharmaceuticals, Inc
PINK USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- P/E ratio
- Not available
- Analyst target
- 2
- Dividend yield
- Not available
- Beta
- 17.05
Profile
Company facts
- Exchange
- PINK
- Currency
- USD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- US03209T1097
- P/E ratio
- Not available
- Analyst target
- 2
- Dividend yield
- Not available
- Beta
- 17.05
About
About Ampio Pharmaceuticals, Inc
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the AMPE discussion.
5 years, 4 months ago
Ampio Pharmaceuticals, Inc is currently in a long term uptrend where the price is trading 5.0% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Ampio Pharmaceuticals, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 352.7% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 39.2% to $-3M since the same quarter in the previous year.
Based on the above factors, Ampio Pharmaceuticals, Inc gets an overall score of 3/5.